glp 1 agonist benefits In patients with #obesity, incretin-based therapies such as GLP-1 receptor agonists are reported to result in mean weight reductions of approximately 15 to 20% along with additional health benefits, including decreased cardiovascular Frontiers | Exploring the multifaceted

PMID: 19249393

This idea was bolstered by a series of experiments conducted between 1890 and 1905 by Marcel Eugne mile Gley, a French physiologist

GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone in the body that plays a crucial role in regulating blood sugar, appetite, and digestion

Potential protective effects may arise from multiple mechanisms, including the complex interplay between weight stigmatization, psychological distress, and improvements in overall health and self-perception among adolescents ( 15 , 16 )

2025 ASCO Annual Meeting

These studies suggest that GLP-1 may mediate cholesterol outflow in hepatocytes through the LXR-ABCA1 pathway, consequently avoiding large amounts of cholesterol accumulation in cells